Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials-Reference-Cited by-同舟云学术

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials

Published:2019 Issue:4 Volume:43 Page:410
ISSN:2233-6079
Container-title:Diabetes & Metabolism Journal
language:en
Short-container-title:Diabetes Metab J

Author:

Kang Yu Mi¹^ORCID,Cho Yun Kyung²^ORCID,Lee Jiwoo²,Lee Seung Eun²,Lee Woo Je²,Park Joong-Yeol²,Kim Ye-Jee³,Jung Chang Hee²^ORCID,Nauck Michael A.⁴^ORCID

Affiliation:

1. International Healthcare Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

3. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

4. Diabetes Center Bochum-Hattingen, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

Publisher

Korean Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.4093/dmj.2018.0070

Reference11 articles.

1. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

2. Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists

3. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

4. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

5. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials;Journal of Clinical Lipidology;2024-07

2. Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing Study;Diabetes & Metabolism Journal;2024-05-31

3. A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD‐JPN);Diabetes, Obesity and Metabolism;2024-05-07

4. Epidemiological and Hemato-Biochemical Profiles of Diabetic Patients at the Diabetology, Endocrinology, and Metabolic Diseases Department of the Alpha Oumar Diallo Regional Hospital, Kindia (Republic of Guinea);Journal of Diabetes Mellitus;2024

5. Efficacy of treatment with glucagon-like peptide receptor agonists-1 in Asian patients with type 2 diabetes mellitus;Problems of Endocrinology;2023-05-11